Our results indicate that the GG genotype of rs4796793 STAT3 polymorphism might be considered a risk factor for CTCL development and it might potentially contribute to disease progression. This evidence concerns the gene STAT3 and primary cutaneous T-cell non-Hodgkin lymphoma.